Allelotypes of primary cutaneous melanoma and benign melanocytic nevi

Cancer Research

Volumn 56, Issue 3, 1996, Pages 589-593

  Healy, Eugene ^a,c   Belgaid, Christine E ^a   Takata, Minoru ^a,e   Vahlquist, Anders ^a,f   Rehman, Ishtiaq ^a,d   Rigby, Howard ^b   Rees, Jonathan L ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^f LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 10Q; CHROMOSOME 18Q; CHROMOSOME 3P; CHROMOSOME 6Q; CHROMOSOME 9P; CHROMOSOME DELETION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MELANOCYTIC NEVUS; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS;

ALLELES; CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; GENE DELETION; HETEROZYGOTE; HUMANS; MELANOMA; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 0030062357     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Elder, D. E. Skin cancer. Melanoma and other specific nonmelanoma skin cancers. Cancer (Phila.), 75 (Suppl.): 245-256, 1995.
2. MacLennan, R., Green, A. C., McLeod, G. R., and Martin, N. G. Increasing incidence of cutaneous melanoma in Queensland, Australia. J. Natl. Cancer Inst , 84: 1427-1432, 1992.
3. MacKie, R., Hunter, J A., Aitchison, T. C., Hole, D., Mclaren, K., Rankin, R., Blessing, K., Evans, A T., Hutcheon, A. W., Jones, D. H., Soutar, D. S., Watson, A. C. H., Cornbleet, M. A., and Smyth, J. F Cutaneous malignant melanoma. Scotland, 1979-89 The Scottish Melanoma Group. Lancet, 339: 971-975, 1992.
4. Breslow, A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg.,172: 902-908, 1970.
5. Johnson, T. M , Smith, J. W. Nelson, B. R. and Chang, A. Current therapy for cutaneous melanoma. J Am. Acad. Dermatol , 32: 689-707, 1995.
6. Fearon, E. R., and Vogelstein. B A genetic model for colorectal tumorigenesis Cell. 61. 759-767, 1990
7. Thibodeau, S. N., Bren, G., and Schaid, D. Microsatellite instability in cancer of the proximal colon. Science (Washington DC), 260: 816-819, 1993
8. Aaltonen, L. A., Peltomaki, P., Leach, F. S., Sistonen, P., Pylkkanen, L., Mecklin, J P., Jarvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., Petersen, G. M., Kinzler, K. W., Vogelstein, B., and de la Chapelle, A. Clues to the pathogenesis of familial colorectal cancer. Science (Washington DC), 260: 812-816, 1993.
9. van't Veer, L. J., Burgering, B. M., Versteeg, R, Boot, A J., Ruiter, D. J., Osanto, S., Schrier, P. I., and Bos, J. L. N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell. Biol.,9: 3114-3116, 1989.
10. Ball, N. J., Yohn, J. J , Morelli, J. G., Norris, D. A., Golitz, L E , and Hoeffler, J. P. Ras mutations in human melanoma, a marker of malignant progression J Invest. Dermatol.,102: 285-290, 1994.
11. Carr, J. and MacKie, R. M. Point mutations in the N-ras oncogene in malignant melanoma and congenital nevi. Br. J. Dermatol.,131: 72-77, 1994.
12. Fountain, J. W., Karayiorgou, M., Ernstoff, M. S., Kirkwood, J M , Vlock, D. R., Titus-Ernstoff, L., Bouchard, B., Vijayasaradhi, S., Houghton, A. N., Lahti, J , Kidd, V. J., Housman, D. E., and Dracopoli, N. C. Homozygous deletions within human chromosome band 9p21 in melanoma. Proc. Natl. Acad. Sci USA, 89: 10557-10561, 1992.
13. Holland, E. A., Beaton, S. C., Edwards, B. G., Kefford, R. F., and Mann, G. J. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma. Oncogene, 9: 1361-1365, 1994.
14. Isshiki, K., Seng, B. A , Elder, D. E., Guerry, D., and Linnenbach, A. J. Chromosome 9 deletion in sporadic and familial melanomas in vivo Oncogene, 9: 1649-1653, 1994
15. Dracopoli, N. C., Harnett, P., Bale, S. J., Stanger, B. Z., Tucker, M. A., Housman, D. E., and Kefford, R. F. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc. Natl. Acad. Sci. USA, 86: 4614-4618, 1989
16. Millikin, D , Meese, E., Vogelstein, B., Witkowski, C., and Trent, J. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res.,51. 5449-5453, 1991.
17. Walker, G J., Palmer, J M , Walters, M. K., Nancarrow, D. J., Parsons, P. G., and Hayward, N. K. Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma. Int. J Cancer, 58: 203-206, 1994.
18. Tomlinson, I. P., Gammack, A. J. Stickland, J. E., Mann, G. J., MacKie, R. M , Kefford, R. F., and McGea, J O. Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in the pathogenesis of other cancers. Genes Chromosomes & Cancer. 7: 169-172, 1993.
19. Isshiki, K , Elder, D. E., Guerry, D., and Linnenbach, A. J. Chromosome 10 allelic loss in malignant melanoma. Genes Chromosomes & Cancer, 8: 178-184, 1993.
20. Cowan, J. M., Halaban, R., and Francke, U Cytogenetic analysis of melanocytes from premalignant nevi and melanomas J. Natl. Cancer Inst.,80: 1159-1164, 1988
21. Richmond, A., Fine, R., Murray, D., Lawson, D. H., and Priest, J. H. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas. J Invest. Dermatol.,86: 295-302, 1986.
22. Trent, J. M , Meyskens, F L., Salmon, S. E., Ryschon, K., Leong, S. P., Davis, J. R., and McGee, D. L. Relation of cytogenetic abnormalities and chrucal outcome in metastatic melanoma. N. Engl. J. Med.,322: 1508-1511, 1990.
23. Healy, E., Rehman, I., Angus, B., and Rees, J. L. Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosomes & Cancer, 12: 152-156, 1995
24. Herbst, R. A., Weiss, J., Ehnis, A., Cavenee, W K., and Arden, K. C. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res. 54: 3111-3114, 1994.
25. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S V . Stockert, E., Day, R. S , 3rd, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
26. Nobori, T , Miura, K. Wu, D J., Lois, A., Takabayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.). 368: 753-756, 1994.
27. Ohta, M., Nagai, H., Shimizu, M., Rasio, D., Berd, D , Mastrangelo, M., Singh, A. D., Shields, J. A., Shields, C. L., Croce, C. M , and Huebner, K. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene. CDK41, in melanoma. Cancer Res.,54: 5269-5272, 1994.
28. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S , Sheahan, M. D., Clark, W H. Jr , Tucker, M. A., and Dracopoli, N. C. Germline p16 mutations in familial melanoma. Nat. Genet.,8: 15-21, 1994.
29. Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., McClure, M., Aitken, J. F , Anderson, D E , Bergman, W , Frants, R , Goldgar, D. E., Green, A., MacLennan, R., Martin, N. G., Meyer, L. J , Youl, P., Zone, J J , Skolnick, M. H., and Cannon-Albright, L. A Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus Nat. Genet , 8 22-26, 1994.
30. Gruis, N. A., van der Velden, P. A , Sandkuijl, LA, Prins, D. E., Weaver-Feldhaus, J , Kamb, A., Bergman, W., and Frants, R. R. Homozygotes for CDNK2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat. Genet.,10: 351-353, 1995.
31. Liu, L., Lassam, N. J., Slingerland, J. M., Bailey, D., Cole, D., Jenkins, R , and Hogg, D. Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma. Oncogene, 11: 405-412, 1995.
32. Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Frye, C., Eeles, R., Orlow, I., Lacombe, L , Ponce-Castaneda, V , Lianes, P., Latres, E., Skolnick, M. H , Cordon-Cardo, C., and Kamb, A. Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression. Am. J. Pathol.,146: 1199-1206, 1995.
33. Reed, J. A., Loganzo, F Jr, Shea, C R., Walker, G. J., Flores, J. F., Glendening, J. M., Bogdany, J. K., Shiel, M. J., Haluska, F. G., Fountain, J. W., and Albino, A P Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression Cancer Res.,55: 2713-2718, 1995.
34. Puig, S., Ruiz, A., Lazaro, C., Castel, T., Lynch, M., Palou, J., Vilalta, A., Weissenbach, J , Mascaro, J. M , and Estivill, X Chromosome 9p deletions in cutaneous malignant melanoma tumors, the minimal deleted region involves markers outside the p16 (CDKN2) gene. Am. J. Hum. Genet.,57: 395-402, 1995.
35. Ackerman, A. B., and Mihara, I. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas. Hum Pathol.,16. 87-91, 1985.
36. Sagebiel, R. W. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of rumor thickness. J Invest Dermatol , 100: 322S-325S, 1993.
37. Clark, W. H., Jr , Reimer, R. R., Greene, M , Ainsworth, A M., and Mastrangelo, M. J Origin of familial malignant melanomas from heritable melanocytic lesions "The B-K mole syndrome." Arch Dermatol.,114: 732-738, 1978.
38. Elder, D. E., Goldman, L. I., Goldman, S. C., Greene, M. H., and Clark, W. H., Jr Dysplastic nevus syndrome a phenotypic association of sporadic cutaneous melanoma. Cancer (Phila.), 46. 1787-1794, 1980.
39. Guerry, D., 4th, Synnestvedt, M., Elder, D E., and Schultz, D. Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J Invest Dermatol.,100: 342S-345S, 1993.
40. Morton, D. L., Davtyan, D G , Wanek, L A., Foshag, L. J., and Cochran, A. J Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness Cancer (Phila.), 71: 3737-3743, 1993.
41. Blakely, F. A , and Freeman, R. G. Nevus of large spindle and/or epithelioid cells (Spitz nevus). In. R. S. Friedman, D S. Rigel, A W Kopf, M. N. Harris, and D Baker (eds.), Cancer of the Skin, pp., 379-389. Philadelphia: W. B. Saunders Co., 1991.
42. Casso, E. M., Grin-Jorgensen, C M., and Grant-Kels, J. M. Spitz nevi J. Am. Acad. Dermatol.,27. 901-913, 1992.
43. Howat, A. J , and Variend, S Lymphatic invasion in Spitz nevi. Am J Surg Pathol. 9: 125-128, 1985.
44. Walker, G. J., Palmer, J. M., Walters, M. K., and Hayward, N. K A genetic model of melanoma tumorigenesis based on allelic losses Genes Chromosomes & Cancer. 12: 134-141, 1995.
45. Fountain, J W , Bale, S. J., Housman, D E., and Dracopoli, N C. Genetics of melanoma. Cancer Surv.,9: 645-671, 1990
46. Jackson, D. P., Hayden, J. D., and Ouirke, P Extraction of nucleic acid from fresh and archival material. In: M J. McPhearson, P Quirke, and G R. Taylor (eds.), PCR, A Practical Approach, pp. 29-50, Oxford: Oxford University Press, 1992
47. Weissenbach, J., Gyapay, G., Dib, C , Vignal, A., Morissette, J , Millasseau, P , Vaysseix, G., and Lathrop, M. A second-generation linkage map of the human genome. Nature (Lond.), 359: 794-801, 1992.
48. Reale, M. A., Hu, G., Zafar, A. I., Getzenberg, R. H., Levine, S. M., and Fearon, E. R. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res.,54: 4493-4501, 1994.
49. Welch, D. R., Chen, P., Miele, M. E., McGary, C. T., Bower, J. M., Stanbridge, E. J., and Weissman, B. E Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit rumorigenicity Oncogene, 9. 255-262, 1994.